Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents
Michael L. Sierra, Véronique Bénéton, Anne-Bénédicte Boullay et al. · Journal of Medicinal Chemistry · 2007
The peroxisome proliferator activated receptors PPARalpha, PPARgamma, and PPARdelta are ligand-activated transcription factors that play a key role in lipid homeostasis. The fibrates raise circulating levels of high-density lipoprotein cholesterol and lower levels of triglycerides in part through their activity as PPARalpha agonists; however, the low potency and restricted selectivity of the fibrates may limit their efficacy, and it would be desirable to develop more potent and selective PPARalpha agonists. Modification of the selective PPARdelta agonist 1 (GW501516) so as to incorporate the 2-aryl-2-methylpropionic acid group of the fibrates led to a marked shift in potency and selectivity toward PPARalpha agonism. Optimization of the series gave 25a, which shows EC50 = 4 nM on PPARalpha and at least 500-fold selectivity versus PPARdelta and PPARgamma. Compound 25a (GW590735) has been progressed to clinical trials for the treatment of diseases of lipid imbalance.
Cited by 120 works. doi:10.1021/jm058056x
Authors
- Michael L. Sierra
- Véronique Bénéton
- Anne-Bénédicte Boullay
- Thierry Boyer
- Andrew G. Brewster
- Frédéric Donche
- Marie-Claire Forest
- Marie-Hélène Fouchet
- Françoise J. Gellibert
- Didier Grillot
- Millard H. Lambert
- Alain Laroze
- Christelle Le Grumelec
- Jean Michel Linget
- Valerie G. Montana
- Van-Loc Nguyen
- Edwige Nicodème
- Annie Penfornis
References
- AMoRe: an automated package for molecular replacement
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- The PPARs: From Orphan Receptors to Drug Discovery
- Nuclear Receptors and Lipid Physiology: Opening the X-Files
- Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
- Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
- Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors
- Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
- An eclipsing millisecond pulsar in the globular cluster Terzan 5